US Bancorp
GDRX icon

US Bancorp’s GoodRx Holdings GDRX Stock Holding History

US Bancorp’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$265K Hold
92,117
– – ﹤0.01% 1956
2026
Q1 		$181K Hold
92,117
– – ﹤0.01% 2073
2025
Q4 		$250K Hold
92,117
– – ﹤0.01% 1917
2025
Q3 		$390K Sell
92,117
-75
-0.1% -$330 ﹤0.01% 1648
2025
Q2 		$459K Hold
92,192
– – ﹤0.01% 1544
2025
Q1 		$407K Buy
92,192
+55
+0.1% +$258 ﹤0.01% 1602
2024
Q4 		$428K Sell
92,137
-3,712
-4% -$20.4K ﹤0.01% 1576
2024
Q3 		$665K Hold
95,849
– – ﹤0.01% 1343
2024
Q2 		$748K Sell
95,849
-13,969
-13% -$103K ﹤0.01% 1251
2024
Q1 		$780K Buy
109,818
+3,877
+4% +$25.6K ﹤0.01% 1241
2023
Q4 		$710K Buy
105,941
+10,588
+11% +$59.6K ﹤0.01% 1301
2023
Q3 		$537K Buy
95,353
+1,363
+1% +$9.09K ﹤0.01% 1336
2023
Q2 		$519K Sell
93,990
-1,601
-2% -$8.62K ﹤0.01% 1378
2023
Q1 		$597K Buy
95,591
+938
+1% +$5.23K ﹤0.01% 1311
2022
Q4 		$441K Buy
94,653
+1,702
+2% +$8.38K ﹤0.01% 1456
2022
Q3 		$434K Sell
92,951
-222
-0.2% -$1.4K ﹤0.01% 1460
2022
Q2 		$552K Sell
93,173
-8,147
-8% -$90.7K ﹤0.01% 1388
2022
Q1 		$1.96M Sell
101,320
-17,826
-15% -$409K ﹤0.01% 894
2021
Q4 		$3.89M Buy
119,146
+2,406
+2% +$96.8K 0.01% 661
2021
Q3 		$4.79M Buy
116,740
+6,899
+6% +$250K 0.01% 576
2021
Q2 		$3.96M Buy
109,841
+92,507
+534% +$3.41M 0.01% 634
2021
Q1 		$677K Buy
17,334
+3,112
+22% +$140K ﹤0.01% 1344
2020
Q4 		$574K Buy
14,222
+4,752
+50% +$218K ﹤0.01% 1371
2020
Q3 		$527K Buy
+9,470
New +$501K ﹤0.01% 1304

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

US Bancorp's GDRX Position: Q2 2026 in Review

US Bancorp held its GoodRx Holdings (GDRX) position steady in Q2 2026 at 92,117 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #1956.

US Bancorp first reported a position in GDRX in Q3 2020 and has held it in 24 quarters since. The position peaked at $4.79M in Q3 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • US Bancorp held 92,117 shares of GoodRx Holdings worth $265K as of Q2 2026.
  • US Bancorp left its GoodRx Holdings share count unchanged in Q2 2026.
  • GoodRx Holdings made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1956 holding.
  • US Bancorp first reported a position in GoodRx Holdings in Q3 2020 and has held it in 24 quarters since.
  • US Bancorp's GoodRx Holdings position peaked at $4.79M in Q3 2021.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.